PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


The 50 Most-Frequently Read Articles
in Perit Dial Int during April 2008 -- updated monthly

Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.

6.  B Piraino, GR Bailie, J Bernardini, E Boeschoten, A Gupta, C Holmes, EJ Kuijper, PK Li, WC Lye, S Mujais, DL Paterson, MP Fontan, A Ramos, F Schaefer, L Uttley, ISPD Ad Hoc Advisory Committee
  Peritoneal dialysis-related infections recommendations: 2005 update
  Perit Dial Int Mar 01, 2005; 25: 107-131.
(In "ARTICLES")   [PDF]
 
7.  Hoon Young Choi, Dong Ki Kim, Tae Hee Lee, Sung Jin Moon, Seung Hyeok Han, Jung Eun Lee, Beom Seok Kim, Hyeong Cheon Park, Kyu Hun Choi, Sung Kyu Ha, Dae-Suk Han, Ho Yung Lee
  THE CLINICAL USEFULNESS OF PERITONEAL DIALYSIS FLUIDS WITH NEUTRAL pH AND LOW GLUCOSE DEGRADATION PRODUCT CONCENTRATION: AN OPEN RANDOMIZED PROSPECTIVE TRIAL
 Current issue Perit Dial Int Mar 01, 2008; 28: 174-182.
(In "Clinical")   [Abstract]     [PDF]
 
8.  Wai-Choong Lye
  CATHETER REMOVAL FOR FUNGAL PERITONITIS: SOONER OR LATER?
 Current issue Perit Dial Int Mar 01, 2008; 28: 130-133.
(In "COMMENTARIES")   [PDF]
 
9.  Graham Woodrow, Yvette Devine, Mary Cullen, Elizabeth Lindley
  APPLICATION OF BIOELECTRICAL IMPEDANCE TO CLINICAL ASSESSMENT OF BODY COMPOSITION IN PERITONEAL DIALYSIS
  Perit Dial Int Sep 01, 2007; 27: 496-502.
(In "CASE COMMENTARIES IN PERITONEAL DIALYSIS")   [Abstract]     [PDF]
 
10.  Renata C.S. Lima, André Barreira, Fernando L. Cardoso, Marcio H.S. Lima, Maurilo Leite
  CIPROFLOXACIN AND CEFAZOLIN AS A COMBINATION FOR EMPIRICAL INITIAL THERAPY OF PERITONEAL DIALYSIS-RELATED PERITONITIS: FIVE-YEAR FOLLOW-UP
  Perit Dial Int Jan 01, 2007; 27: 56-60.
(In "Clinical")   [Abstract]     [PDF]
 
[Previous 5 Articles]    [Next 5 Articles]

Current issue = from the current issue

Last Updated: 05/04/2008 05:16:34


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Multimed Inc. logo
Copyright © 2008 by Multimed Inc.